Vonafexor

Overview

Vonafexor (EYP001) is an orally active, non-steroidal and selective FXR agonist. Vonafexor shows significant HBsAg reduction when combined with Peg-IFNα. Vonafexor can be used for anti- HBV research.

Application

Products | Products > Disease Areas > Digestive System Inflammation | Products > Disease Areas > Infection | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Viral Infection | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > FXR | Products > Signaling Pathways > HBV

Product Information

• Catalog No.: HY-109197
• CAS No.: 1192171-69-9
• Molecular Formula: C19H15Cl3N2O5S
• Molecular Weight: 489.76
• Purity: 99.38%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.08 mg/mL (4.25 mM); Clear solution
• Availability: In-stock

Source

Original product source